Abstract:Objective:This study focuses on Na +-taurocholate cotransporting polypeptide (NTCP) deficiency to analyze and investigate the value of the serum bile acid profile for facilitating the diagnosis and differential diagnosis. Methods:Clinical data of 66 patients with cholestatic liver diseases (CLDs) diagnosed and treated in the Department of Pediatrics of the First Affiliated Hospital of Jinan University from early April 2015 to the end of December 2021 were collected, including 32 cases of NTCP deficiency (16 adults and 16 children), 16 cases of neonatal intrahepatic cholestasis caused by citrin deficiency (NICCD), 8 cases of Alagille syndrome, and 10 cases of biliary atresia. At the same time, adult and pediatric healthy control groups (15 cases each) were established. The serum bile acid components of the study subjects were qualitatively and quantitatively analyzed by ultra-high performance liquid chromatography-tandem mass spectrometry. The data were plotted and compared using statistical SPSS 19.0 and GraphPad Prism 5.0 software. The clinical and bile acid profiles of children with NTCP deficiency and corresponding healthy controls, as well as differences between NTCP deficiency and other CLDs, were compared using statistical methods such as t-tests, Wilcoxon rank sum tests, and Kruskal-Wallis H tests.Results:Compared with the healthy control, the levels of total conjugated bile acids, total primary bile acids, total secondary bile acids, glycocholic acid, taurocholic acid, and glycochenodeoxycholic acid were increased in NTCP deficiency patients ( P < 0.05). Compared with adults with NTCP deficiency, the levels of total conjugated bile acids and total primary bile acids were significantly increased in children with NTCP deficiency ( P < 0.05). The serum levels of taurochenodeoxycholic acid, glycolithocholate, taurohyocholate, and tauro-α-muricholic acid were significantly increased in children with NTCP deficiency, but the bile acid levels such as glycodeoxycholic acid, glycolithocholate, and lithocholic acid were decreased ( P < 0.05). The serum levels of secondary bile acids such as lithocholic acid, deoxycholic acid, and hyodeoxycholic acid were significantly higher in children with NTCP deficiency than those in other CLD groups such as NICCD, Alagille syndrome, and biliary atresia ( P < 0.05). Total primary bile acids/total secondary bile acids, total conjugated bile acids/total unconjugated bile acids, taurocholic acid, serum taurodeoxycholic acid, and glycodeoxycholic acid effectively distinguished children with NTCP deficiency from other non-NTCP deficiency CLDs. Conclusion:This study confirms that serum bile acid profile analysis has an important reference value for facilitating the diagnosis and differential diagnosis of NTCP deficiency. Furthermore, it deepens the scientific understanding of the changing characteristics of serum bile acid profiles in patients with CLDs such as NTCP deficiency, provides a metabolomic basis for in-depth understanding of its pathogenesis, and provides clues and ideas for subsequent in-depth research.

Increased Sulfation of Bile Acids in Mice and Human Subjects with Sodium Taurocholate Cotransporting Polypeptide Deficiency.

Biochemical and Bioinformatic Characterization of Patients with a Sodium Taurocholate Cotransporting Polypeptide Mutation

Clinical and molecular study of a pediatric patient with sodium taurocholate cotransporting polypeptide deficiency

Homozygous P.ser267phe in SLC10A1 is Associated with a New Type of Hypercholanemia and Implications for Personalized Medicine

Abnormal Bilirubin Metabolism in Patients With Sodium Taurocholate Cotransporting Polypeptide Deficiency

NTCP Deficiency Affects the Levels of Circulating Bile Acids and Induces Osteoporosis

SLC10A5 deficiency causes hypercholanemia

Sodium taurocholate cotransporting polypeptide (SLC10A1) deficiency: conjugated hypercholanemia without a clear clinical phenotype

Monozygotic Twins Suffering From Sodium Taurocholate Cotransporting Polypeptide Deficiency: A Case Report

Hepatic Tmem30a Deficiency Causes Intrahepatic Cholestasis by Impairing Expression and Localization of Bile Salt Transporters.

Sodium Taurocholate Cotransporting Polypeptide (NTCP) Deficiency: Identification of a Novel SLC10A1 Mutation in Two Unrelated Infants Presenting with Neonatal Indirect Hyperbilirubinemia and Remarkable Hypercholanemia

Clinical and Molecular Characterization of Four Patients with NTCP Deficiency from Two Unrelated Families Harboring the Novel SLC10A1 Variant C.595a>c (P.ser199arg)

[Clinical and genetic analysis of a pediatric patient with sodium taurocholate cotransporting polypeptide deficiency].

Regulation of Bile Acid Biosynthesis by Hepatocyte Nuclear Factor 4Α

Clinical Phenotypic Characterization of NTCP Deficiency in Humans: A Case-Control Study Based on SLC10A1 Genotyping Analysis

Loss of apical sodium bile acid transporter alters bile acid circulation and reduces biliary damage in cholangitis

Research advances in the pathogenesis,clinical manifestations,and diagnosis/treatment of sodium-taurocholate co-transporting polypeptide deficiency

[Sodium taurocholate cotransporting polypeptide deficiency manifesting as cholestatic jaundice in early infancy: a complicated case study].

Clinical and histopathologic features of sodium taurocholate cotransporting polypeptide deficiency in pediatric patients.

NTCP Deficiency Causes Gallbladder Abnormalities in Mice and Human Beings

Analysis of the Serum Bile Acid Profile to Facilitate Diagnosis and Differential Diagnosis of NA +-Taurocholate Cotransporting Polypeptide Deficiency